Nakornthon Hospital PCL (BKK:NKT) ROE %: 1.51% (As of Mar. 2026) — 91% Below Median


BKK:NKT Nakornthon Hospital PCL BKK:NKT
19 GF Score
Price ฿3.76
! 5 Warning Signs
View Full Analysis

What is Nakornthon Hospital PCL ROE %?

Nakornthon Hospital PCL BKK:NKT -1.57% 19 ROE % is 1.51% as of Mar. 2026, which is 91% below its 10-year median of 16.42. GuruFocus rates BKK:NKT with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 626 Healthcare Providers & Services companies, Nakornthon Hospital PCL ranks better than 54.47% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Nakornthon Hospital PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿31 Mil. Nakornthon Hospital PCL's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ฿2,023 Mil. Therefore, Nakornthon Hospital PCL's annualized ROE % for the quarter that ended in Mar. 2026 was 1.51%.

The historical rank and industry rank for Nakornthon Hospital PCL's ROE % or its related term are showing as below:

BKK:NKT' s ROE % Range Over the Past 10 Years
Min: 7.38   Med: 16.42   Max: 23.51
Current: 7.38

During the past 4 years, Nakornthon Hospital PCL's highest ROE % was 23.51%. The lowest was 7.38%. And the median was 16.42%.

BKK:NKT's ROE % is ranked better than
54.47% of 626 companies
in the Healthcare Providers & Services industry
Industry Median: 5.805 vs BKK:NKT: 7.38

Nakornthon Hospital PCL  (BKK:NKT) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=30.624/2022.921
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(30.624 / 1944.396)*(1944.396 / 2785.5395)*(2785.5395 / 2022.921)
=Net Margin %*Asset Turnover*Equity Multiplier
=1.57 %*0.698*1.377
=ROA %*Equity Multiplier
=1.1 %*1.377
=1.51 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=30.624/2022.921
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (30.624 / 87.908) * (87.908 / 93.576) * (93.576 / 1944.396) * (1944.396 / 2785.5395) * (2785.5395 / 2022.921)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.3484 * 0.9394 * 4.81 % * 0.698 * 1.377
=1.51 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Nakornthon Hospital PCL ROE % Related Terms


Nakornthon Hospital PCL ROE % Historical Data

* Premium members only.

The historical data trend for Nakornthon Hospital PCL's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nakornthon Hospital PCL ROE % Chart

Nakornthon Hospital PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROE %
23.51 19.39 13.45 9.90

Nakornthon Hospital PCL Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.47 8.62 12.73 6.93 1.51

BKK:NKT vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Nakornthon Hospital PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nakornthon Hospital PCL ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nakornthon Hospital PCL's ROE % distribution charts can be found below:

* The bar in red indicates where Nakornthon Hospital PCL's ROE % falls into.


BKK:NKT
19GF Score
Nakornthon Hospital PCL BKK:NKT
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nakornthon Hospital PCL ROE % Calculation

Nakornthon Hospital PCL's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=195.352/( (1927.629+2019.093)/ 2 )
=195.352/1973.361
=9.90 %

Nakornthon Hospital PCL's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=30.624/( (2019.093+2026.749)/ 2 )
=30.624/2022.921
=1.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 1.51% mean?
Nakornthon Hospital PCL (BKK:NKT) has a ROE % of 1.51% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Nakornthon Hospital PCL and its competitors. This is 91% below median its historical median of 16.42. Over the past decade, Nakornthon Hospital PCL's ROE % has ranged from 7.38 to 23.51. According to the industry distribution chart, Nakornthon Hospital PCL ranks #285 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is Nakornthon Hospital PCL's ROE % too high?
Nakornthon Hospital PCL's current ROE % of 1.51% is 91% below median its 10-year median of 16.42. Over the past 10 years, this metric has ranged from a low of 7.38 to a high of 23.51. The Healthcare Providers & Services industry median ROE % is 5.81. Nakornthon Hospital PCL's value of 1.51% is 74% below this industry median. Based on the distribution chart, Nakornthon Hospital PCL ranks #285 out of 626 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nakornthon Hospital PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Nakornthon Hospital PCL's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nakornthon Hospital PCL ranks #285 out of 626 companies for ROE %. This puts Nakornthon Hospital PCL in the upper half of its industry. The industry median ROE % is 5.81. Nakornthon Hospital PCL's value of 1.51% is 74% below this benchmark. Historically, Nakornthon Hospital PCL's own ROE % has ranged from 7.38 to 23.51 over the past decade. While the company's 10-year median is 16.42 vs. the industry median of 5.81, Nakornthon Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nakornthon Hospital PCL's current ROE % of 1.51% is 74% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Nakornthon Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nakornthon Hospital PCL's current ROE % is 1.51%, which is 91% below median its own 10-year median of 16.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakornthon Hospital PCL stock overvalued right now?
Nakornthon Hospital PCL (BKK:NKT) has a current ROE % of 1.51%. The current ROE % is 1.51%, which is 91% below median its 10-year median of 16.42 and 74% below the Healthcare Providers & Services industry median of 5.81. Nakornthon Hospital PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Nakornthon Hospital PCL (BKK:NKT), the current ROE % is 1.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nakornthon Hospital PCL Business Description

Address 1 Soi Rama II, Soi 56, Samaedum Subdistrict, Bang Khun Thian District, Bangkok, THA, 10150
Nakornthon Hospital PCL is engaged in the healthcare industry. It is principally engaged in the hospital business offering specialty centers such as Orthopedics Center, Neurology Center, Gastrointestinal and Liver Center, and Nakornthon Fertility Center by Superior A.R.T. The company has two reportable segments which are hospital operations and other businesses that support hospital business including distribution of health and cosmetic products, facility management, and restaurant. A majority of its revenue is generated from the hospital business. Its operations are carried on in the geographical area of Thailand.
19GF Score

Get the complete analysis for BKK:NKT

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿3.76
Price